https://www.selleckchem.com/pr....oducts/cobimetinib-g
The PROSPERO ID for this study is CRD42021249089.In recent years, the incidence of depression is rising rapidly worldwide, but large-scale depression screening is still challenging. Gait analysis provides a non-contact, low-cost, and efficient early screening method for depression. However, the early screening of depression based on gait analysis lacks sufficient effective sample data. In this paper, we propose a skeleton data augmentation method for assessing the risk of depression. First, we propose five techniques
Aimer
Commentaire
Partagez
